We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
-21.51%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$8.43B
AUM Growth
-$8.39B
Cap. Flow
-$5.17B
Cap. Flow %
-61.29%
Top 10 Hldgs %
10.82%
Holding
1,704
New
583
Increased
218
Reduced
300
Closed
598

Sector Composition

Rank Sector Weight
1 Healthcare 14.65%
2 Technology 14.28%
3 Financials 13.93%
4 Consumer Discretionary 13.37%
5 Industrials 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CZR
1701
DELISTED
Caesars Entertainment Corporation
CZR
-343,249
Closed -$4.04M
AZPN
1702
DELISTED
ASPEN TECHNOLOGY INC
AZPN
-43,493
Closed -$5.26M
AAN.A
1703
DELISTED
The Aaron's Company Inc Class A
AAN.A
-653,092
Closed -$37.3M
HR
1704
DELISTED
Healthcare Realty Trust Incorporated
HR
-496,091
Closed -$16.6M

Similar funds

Dmitry Balyasny's Q1 2020 Portfolio in Review

As of Q1 2020, Dmitry Balyasny held 1,704 positions worth $8.43B, down 50% from $16.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Dmitry Balyasny withdrew a net $5.17B in Q1 2020, closing 598 positions and reducing 300 holdings. Its most notable exit was American International, an estimated $193M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

Against the trend, Dmitry Balyasny opened a new position in Lowe's Companies worth $86M.

  • Dmitry Balyasny's largest Q1 2020 buy was Lowe's Companies: 999,686 shares worth $86M.
  • Dmitry Balyasny added most to Boston Scientific in Q1 2020, an estimated $72.4M increase.
  • Dmitry Balyasny's biggest Q1 2020 reduction was ExxonMobil, cutting an estimated $121M.
  • Dmitry Balyasny fully exited American International in Q1 2020, selling an estimated $193M.
  • Dmitry Balyasny's ten largest holdings make up 11% of its $8.43B portfolio in Q1 2020.
  • Dmitry Balyasny opened 583 new positions and closed 598 in Q1 2020.
  • Dmitry Balyasny's portfolio value fell 50% quarter-over-quarter to $8.43B.

Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.